Advertisement

Citations to this article

Abstract

Persistently activated or tyrosine-phosphorylated STAT3 (pSTAT3) is found in 50% of lung adenocarcinomas. pSTAT3 is found in primary adenocarcinomas and cell lines harboring somatic-activating mutations in the tyrosine kinase domain of EGFR. Treatment of cell lines with either an EGFR inhibitor or an src kinase inhibitor had no effect on pSTAT3 levels, whereas a pan-JAK inhibitor (P6) blocked activation of STAT3 and inhibited tumorigenesis. Cell lines expressing these persistently activated mutant EGFRs also produced high IL-6 levels, and blockade of the IL-6/gp130/JAK pathway led to a decrease in pSTAT3 levels. In addition, reduction of IL-6 levels by RNA interference led to a decrease in tumorigenesis. Introduction of persistently activated EGFR into immortalized breast epithelial cells led to tumorigenesis, IL-6 expression, and STAT3 activation, all of which could be inhibited with P6 or gp130 blockade. Furthermore, inhibition of EGFR activity in multiple cell lines partially blocked transcription of IL-6 and concurrently decreased production and release of IL-6. Finally, immunohistochemical analysis revealed a positive correlation between pSTAT3 and IL-6 positivity in primary lung adenocarcinomas. Therefore, mutant EGFR could activate the gp130/JAK/STAT3 pathway by means of IL-6 upregulation in primary human lung adenocarcinomas, making this pathway a potential target for cancer treatment.

Authors

Sizhi Paul Gao ... Bayard Clarkson, Jacqueline F. Bromberg

×

Total citations by year in Crossref

Year: 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 1 32 25 24 19 19 26 11 1 158
Citation information

Citations to this article in Crossref (158)

Title and authors Publication Year
Smoking-Induced CXCL14 Expression in the Human Airway Epithelium Links Chronic Obstructive Pulmonary Disease to Lung Cancer
R Shaykhiev, R Sackrowitz, T Fukui, WL Zuo, IW Chao, Y Strulovici-Barel, RJ Downey, RG Crystal
American journal of respiratory cell and molecular biology 2013
STAT3 expression correlates with prognosis of thymic epithelial tumors
C Li, Z Wang, Y Liu, P Wang, R Zhang
Journal of Cardiothoracic Surgery 2013
STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor
Y Wang, AH van Boxel-Dezaire, H Cheon, J Yang, GR Stark
Proceedings of the National Academy of Sciences 2013
Erlotinib-Induced Thrombocytosis in Patients With Recurrence of Pancreatic Cancer After Distal Pancreatectomy:
T Uwagawa, T Misawa, Y Fujiwara, K Furukawa, N Tsutsui, H Kitamura, H Shiba, Y Futagawa, K Aiba, K Yanaga
Pancreas 2013
Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer
J Kumar, FW Fraser, C Riley, N Ahmed, DR McCulloch, AC Ward
British Journal of Cancer 2013
Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma
Y Katanasaka, Y Kodera, Y Kitamura, T Morimoto, T Tamura, F Koizumi
Molecular Cancer 2013
Establishing the role of tyrosine kinase 2 in cancer
C Ubel, S Mousset, D Trufa, H Sirbu, S Finotto
OncoImmunology 2013
Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically
TL Putoczki, S Thiem, A Loving, RA Busuttil, NJ Wilson, PK Ziegler, PM Nguyen, A Preaudet, R Farid, KM Edwards, Y Boglev, RB Luwor, A Jarnicki, D Horst, A Boussioutas, JK Heath, OM Sieber, I Pleines, BT Kile, A Nash, FR Greten, BS McKenzie, M Ernst
Cancer Cell 2013
STAT3 as a therapeutic target for Epstein-Barr virus (EBV) – associated nasopharyngeal carcinoma
Y Ho, SW Tsao, M Zeng, VW Lui
Cancer Letters 2012
Acetylation modulates the STAT signaling code
M Wieczorek, T Ginter, P Brand, T Heinzel, OH Krämer
Cytokine & Growth Factor Reviews 2012
Stat3: Linking inflammation to (gastrointestinal) tumourigenesis
M Ernst, TL Putoczki
Clinical and Experimental Pharmacology and Physiology 2012
EGFR inhibitor BIBU induces apoptosis and defective autophagy in glioma cells
R Ghildiyal, D Dixit, E Sen
Molecular Carcinogenesis 2012
DNA damage induces the IL-6/STAT3 signaling pathway, which has anti-senescence and growth-promoting functions in human tumors
UJ Yun, SE Park, YS Jo, J Kim, DY Shin
Cancer Letters 2012
Radioimmunoimaging with Mixed Monoclonal Antibodies of Nude Mice Bearing Human Lung Adenocarcinoma Xenografts
D Duan, SL Li, YQ Zhu, T Zhang, CM Lei, XH Cheng
Asian Pacific Journal of Cancer Prevention 2012
Cytotoxic Chemotherapy and CD4+ Effector T Cells: An Emerging Alliance for Durable Antitumor Effects
ZC Ding, G Zhou
Clinical and Developmental Immunology 2012
Interleukin-6 signaling pathway in targeted therapy for cancer
Y Guo, F Xu, TJ Lu, Z Duan, Z Zhang
Cancer Treatment Reviews 2012
STAT3 negatively regulates thyroid tumorigenesis
JP Couto, L Daly, A Almeida, JA Knauf, JA Fagin, M Sobrinho-Simões, J Lima, V Máximo, P Soares, D Lyden, JF Bromberg
Proceedings of the National Academy of Sciences 2012
Involvement of STAT3, NF-κB and associated downstream molecules before and after the onset of urethane induced lung tumors in mouse
M Pandey, KP Gupta
Environmental Toxicology and Pharmacology 2012
Effect of 5-FU and MTX on the Expression of Drug-resistance Related Cancer Stem Cell Markers in Non-small Cell Lung Cancer Cells
H Yi, HJ Cho, SM Cho, K Jo, JA Park, SH Lee, BJ Chang, JS Kim, HC Shin
The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 2012
Determinants of the extent and duration of STAT3 signaling
B Groner
JAK-STAT 2012
JAK2-related pathway induces acquired erlotinib resistance in lung cancer cells harboring an epidermal growth factor receptor-activating mutation
D Harada, N Takigawa, N Ochi, T Ninomiya, M Yasugi, T Kubo, H Takeda, E Ichihara, K Ohashi, S Takata, M Tanimoto, K Kiura
Cancer Science 2012
p14ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway
P Ozenne, D Dayde, E Brambilla, B Eymin, S Gazzeri
Oncogene 2012
Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling
X Jin, SH Kim, HM Jeon, S Beck, YW Sohn, J Yin, JK Kim, YC Lim, JH Lee, SH Kim, SH Kang, X Pian, MS Song, JB Park, YS Chae, YG Chung, SH Lee, YJ Choi, DH Nam, YK Choi, H Kim
Brain 2012
Contribution of Fibroblast and Mast Cell (Afferent) and Tumor (Efferent) IL-6 Effects within the Tumor Microenvironment
HJ Hugo, S Lebret, E Tomaskovic-Crook, N Ahmed, T Blick, DF Newgreen, EW Thompson, ML Ackland
Cancer Microenvironment 2012
Pyruvate Kinase M2 Regulates Gene Transcription by Acting as A Protein Kinase
X Gao, H Wang, JY Jenny, X Liu, ZR Liu
Molecular Cell 2012

Advertisement
Advertisement